Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures

PLoS One. 2015 Mar 25;10(3):e0119086. doi: 10.1371/journal.pone.0119086. eCollection 2015.

Abstract

Ex vivo expansion of hematopoietic stem and progenitor cells (HSPC) is a promising approach to improve insufficient engraftment after umbilical cord blood stem cell transplantation (UCB-SCT). Although culturing HSPC with hematopoietic cytokines results in robust proliferation, it is accompanied with extensive differentiation and loss of self-renewal capacity. Wnt signaling has been implicated in regulating HSPC fate decisions in vivo and in promoting HSPC self-renewal by inhibition of differentiation, but the effects of Wnt on the ex vivo expansion of HSPC are controversial. Here, we demonstrate that exogenous Wnt3a protein suppresses rather than promotes the expansion of UCB-derived CD34+ cells in serum free expansion cultures. The reduced expansion was also observed in cultures initiated with Lin-CD34+CD38lowCD45RA-CD90+ cells which are highly enriched in HSC and was also observed in response to activation of beta-catenin signaling by GSK3 inhibition. The presence of Wnt3a protein during the culture reduced the frequency of multilineage CFU-GEMM and the long-term repopulation ability of the expanded HSPC. These data suggest that Wnt signaling reduces expansion of human HSPC in growth factor-driven expansion cultures by promoting differentiation of HSPC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD34 / metabolism
  • Cell Differentiation / drug effects
  • Cell Lineage
  • Cells, Cultured
  • Culture Media, Serum-Free / chemistry*
  • Fetal Blood / cytology
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Liposomes / chemistry
  • Mice
  • Mice, Inbred NOD
  • Parkinson Disease / therapy
  • Receptors, Aryl Hydrocarbon / antagonists & inhibitors
  • Receptors, Aryl Hydrocarbon / metabolism
  • Stem Cells / cytology
  • Stem Cells / drug effects*
  • Stem Cells / metabolism
  • Wnt Signaling Pathway / drug effects*
  • Wnt3A Protein / genetics
  • Wnt3A Protein / metabolism
  • Wnt3A Protein / pharmacology*
  • beta Catenin / metabolism

Substances

  • Antigens, CD34
  • Culture Media, Serum-Free
  • Liposomes
  • Receptors, Aryl Hydrocarbon
  • Wnt3A Protein
  • beta Catenin
  • Glycogen Synthase Kinase 3

Grants and funding

This work was supported by a grant from TI Pharma and performed within the framework of the TIPharma Project D5-402: ‘The Prograft Study: optimizing the applicability of stem cell therapy’ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.